Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum

Bennett, J. M., Ward, K. E., Muir, R. K., Kabeche, S., Yoo, E., Yeo, T., Lam, G., Zhang, H., Almaliti, J., Berger, G., Faucher, F. F., Lin, G., Gerwick, W. H., Yeh, E., Fidock, D. A., & Bogyo, M. (2023). Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum. ACS Infectious Diseases, 9(10), 2036–2047. https://doi.org/10.1021/acsinfecdis.3c00310
Authors:
John M Bennett
Kurt E Ward
Ryan K Muir
Stephanie Kabeche
Euna Yoo
Tomas Yeo
Grace Lam
Hao Zhang
Jehad Almaliti
Gabriel Berger
Franco F Faucher
Gang Lin
William H Gerwick
Ellen Yeh
David A Fidock
Matthew Bogyo
Affiliated Authors:
Kurt E Ward
Tomas Yeo
David A Fidock
Author Keywords:
antimicrobial resistance
cyclic peptides
plasmodium falciparum
plasmodium falciparum;
Publication Type:
Article
Unique ID:
10.1021/acsinfecdis.3c00310
PMID:
Publication Date:
Data Source:
PubMed

Record Created: